About Rqmicro
Rqmicro is a company based in Zurich (Switzerland) founded in 2013 by Hans-Anton Keserue and Daniel Schaffhauser. Rqmicro has raised $6.46 million across 8 funding rounds from investors including European Union and EIC Fund. Rqmicro operates in a competitive market with competitors including OpGen, Neogen, Parse Biosciences, Qiagen and Biofidelity, among others.
- Headquarter Zurich, Switzerland
- Founders Hans-Anton Keserue, Daniel Schaffhauser
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website rqmicro.com
- Social LinkedIn X Facebook YouTube
- Total Equity Funding$6.46M (USD)
in 8 rounds
- Latest Funding Round$58.69K (USD), Grant
Mar 2021
- InvestorsEuropean Union
& 1 more
Apps and channels of Rqmicro
its YouTube channel rqmicro has 21 subscribers and 11 videos.
Videos from Rqmicro
The most watched videos on Rqmicro's YouTube channel, rqmicro (21 subscribers). Click a video to play it here.
More on rqmicro.
Funding Insights of Rqmicro
Rqmicro has successfully raised a total of $6.46M across 8 strategic funding rounds. The most recent funding activity was a Grant round of $58.69 thousand completed in March 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $6.46M
- Total Rounds 8
- Last Round Grant — $58,688
- Investors Count 2
All 8 funding rounds of Rqmicro with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2021 | $58,688 | Grant | – | – | |
| Mar 2021 | $6.46M | Series B | – | – | – |
| Sep 2018 | $2.55M | Grant | – | – | – |
| Feb 2018 | $61,458 | Grant | – | – | |
| Nov 2017 | – | Grant | – | – | |
| Nov 2017 | $58,140 | Grant | – | – | – |
| Jan 2017 | $52,973 | Grant | – | – | |
| Jun 2016 | – | Series A | – | – | – |
2 investors in total: 2 institutional.
Investors in Rqmicro
Rqmicro has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union and EIC Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government agency and accelerator focusing on innovative startups and SMEs | – | eicfund.eu | Brussels, Belgium | |
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for Rqmicro
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Rqmicro
2 people are tracked at Rqmicro (2 in leadership).
| Name | Role | Group |
|---|---|---|
Hans-Anton Keserue | Co-Founder & CEO | Leadership |
Daniel Schaffhauser | Co-Founder & CTO | Leadership |
Complete people profiles for Rqmicro
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Rqmicro
3 dated milestones of Rqmicro across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Rqmicro is founded.
- Funding First funding round.
- Funding Latest funding round, Grant, of $59K.
Competitors of Rqmicro
Rqmicro operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as OpGen, Neogen, Parse Biosciences, Qiagen and Biofidelity, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| opgen.com | 2002 | Rockville, United States | $77.51M | 100 | Developer of diagnostics and bioinformatics platforms for providers | |
| neogen.com | 1982 | Lansing, United States | $700,000 | 2,640 | Manufacturer of products in the areas of veterinary diagnostics, life sciences, DNA testing, and drug testing | |
| parsebiosciences.com | 2018 | Seattle, United States | $100.26M | – | RNA-sequencing transcriptome kits for health data analysis are developed. | |
| qiagen.com | 1984 | Hilden, Germany | – | 104 | Products and reagents for molecular diagnostic assays are supplied. | |
| biofidelity.com | 2002 | Cambridge, United Kingdom | $59.91M | 28 | Molecular diagnostic assays are developed for target DNA sequence detection. | |
| fluentbio.com | 2018 | Watertown, United States | $19M | – | Proprietary reagents for single-cell genetic analysis are developed. | |
| rarecyte.com | 2009 | Seattle, United States | $114.33M | 54 | Developer of technologies for the analysis of rare and single cells in the blood | |
| sebia.com | 1967 | Evry Courcouronnes, France | – | – | Electrophoresis-based in vitro diagnostics products are developed and provided. | |
| nuprobe.com | 2016 | George Town, Cayman Islands | $61M | – | Sensitive multiplex platforms for QPCR are developed using toehold probes. |
Detailed competitors of Rqmicro
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Rqmicro
The website of Rqmicro (rqmicro.com) receives about 2.2K visits a month.
- Monthly visits2.2K
▼ 9.8% vs previous month
Latest news on Rqmicro
Complete news archive for Rqmicro
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Rqmicro
10 companies that operate in the same segment as Rqmicro (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Rqmicro
Rqmicro was founded in 2013 and raised its 1st funding round 3 years after it was founded.
Rqmicro is headquartered in Zurich, Switzerland.
Hans-Anton Keserue is the current CEO of Rqmicro. They have also founded this company.
Rqmicro is a funded company, having raised a total of $6.46M across 8 funding rounds to date.
Rqmicro was founded in 2013 in Zurich, Switzerland, within the biotechnology sector. Instruments, reagents, and kits for rapid pathogen detection are produced, including a sample preparation system. Detection services are offered, where immunomagnetic separation is used to isolate target cells from samples, followed by flow cytometry analysis for evaluation. Operations center on enhancing pathogen identification processes.
Rqmicro's top competitors include Neogen, Qiagen and Parse Biosciences.
Rqmicro has 2 investors. Key investors include European Union, and EIC Fund.